Block Listing Update

RNS Number : 2604F

Futura Medical PLC

22 May 2013

 



For immediate release

22 May 2013

Futura Medical plc

("Futura" or "the Company")

Block Listing Update

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that, in the six months since the previous block admission update on 22 November 2012, the following changes have taken place:

Futura Medical plc Option Plan		Block Listed 25 May 2011	Block Listing Brought Forward		Options Exercised in Period	Options Lapsed in Period		Block Listing Carried Forward
Unapproved Share Option Scheme		814,424	684,155		-	-		684,155
EMI Share Option Scheme		1,520,576	790,124		(142,038)	(100,000)		548,086
		2,335,000	1,474,279		(142,038)	(100,000)		1,232,241

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles www.buchanan.uk.com	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

BLRPGUWAAUPWGAG